XML 30 R23.htm IDEA: XBRL DOCUMENT v3.25.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
Summary of Disaggregated Amounts of Operating Expenses

The following table presents information about reported segment loss and significant segment expenses for the three and nine months ended September 30, 2025 and 2024 (in thousands):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Segment research and development (a) (b)

 

$

(3,627

)

 

$

(3,265

)

 

$

(11,330

)

 

$

(9,988

)

Segment general and administrative (a) (b)

 

 

(1,354

)

 

 

(1,676

)

 

 

(5,016

)

 

 

(6,319

)

Stock-based compensation (see Note 7)

 

 

(626

)

 

 

(781

)

 

 

(2,349

)

 

 

(1,681

)

Depreciation expense

 

 

(11

)

 

 

(14

)

 

 

(41

)

 

 

(44

)

Operating loss

 

$

(5,618

)

 

$

(5,736

)

 

$

(18,736

)

 

$

(18,032

)

Reconciliation of profit or loss

 

 

 

 

 

 

 

 

 

 

 

 

Adjustments and reconciling items

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated operating loss

 

$

(5,618

)

 

$

(5,736

)

 

$

(18,736

)

 

$

(18,032

)

a)
Stock-based compensation expense of $219,000 and $273,000 related to research and development and $407,000 and $508,000 related to general and administrative have been excluded for the three months ended September 30, 2025 and 2024. Stock-based compensation expense of $777,000 and $634,000 related to research and development and $1,572,000 and $1,047,000 related to general and administrative have been excluded for the nine months ended September 30, 2025 and 2024. All amounts are included within stock-based compensation expense.
b)
Depreciation expense of $5,000 and $8,000 related to research and development and $6,000 and $7,000 related to general and administrative have been excluded for the three months ended September 30, 2025 and 2024. Depreciation expense of $19,000 and $24,000 related to research and development and $22,000 and $20,000 related to general and administrative have been excluded for the nine months ended September 30, 2025 and 2024. All amounts are included within depreciation expense.